First, aberrant promoter methylation of IGFBP‐3 gene, which silences its expression, is detected in human gastric cancer, colorectal cancer, breast cancer, and malignant mesothelioma cancer.20 The gene discussed is IGFBP3; the disease is colorectal cancer.